Cannabinoid receptors 1 and 2 (CB1 and CB2), their distribution, ligands and functional involvement in nervous system structures--a short review.
about
Substrate-Selective Inhibition of Cyclooxygenase-2: Development and Evaluation of Achiral Profen ProbesDistribution of CB2 cannabinoid receptor in adult rat retinaMethanandamide attenuates cocaine-induced hyperthermia in rats by a cannabinoid CB1-dopamine D2 receptor mechanismDissimilar interaction of CB1/CB2 with lipid bilayers as revealed by molecular dynamics simulation.Spatial distribution of cannabinoid receptor type 1 (CB1) in normal canine central and peripheral nervous system.The endocannabinoid system: potential for reducing cardiometabolic riskUse of a synthetic cannabinoid in a correctional population for posttraumatic stress disorder-related insomnia and nightmares, chronic pain, harm reduction, and other indications: a retrospective evaluation.In vivo SPECT and ex vivo autoradiographic brain imaging of the novel selective CB1 receptor antagonist radioligand [125I]SD7015 in CB1 knock-out and wildtype mouse.Beneficial metabolic effects of CB1R anti-sense oligonucleotide treatment in diet-induced obese AKR/J mice.Cannabinoid type 1 and type 2 receptor antagonists prevent attenuation of serotonin-induced reflex apneas by dronabinol in Sprague-Dawley rats.Dimerization with cannabinoid receptors allosterically modulates delta opioid receptor activity during neuropathic pain.Inhibition of human tumour prostate PC-3 cell growth by cannabinoids R(+)-Methanandamide and JWH-015: involvement of CB2Cannabinoid receptor expression in HIV encephalitis and HIV-associated neuropathologic comorbidities.Trisubstituted Sulfonamides: a New Chemotype for Development of Potent and Selective CB2 Receptor Inverse Agonists.Cell-penetrating and neurotargeting dendritic siRNA nanostructures.Classification of scaffold-hopping approachesCannabis-related episodic memory deficits and hippocampal morphological differences in healthy individuals and schizophrenia subjectsCannabis-induced impairment of learning and memory: effect of different nootropic drugsCannabinoid type-1 receptor reduces pain and neurotoxicity produced by chemotherapy.Cannabis, Cigarettes, and Their Co-Occurring Use: Disentangling Differences in Gray Matter Volume.Latest advances in novel cannabinoid CB(2) ligands for drug abuse and their therapeutic potential.Simultaneous Activation of Induced Heterodimerization between CXCR4 Chemokine Receptor and Cannabinoid Receptor 2 (CB2) Reveals a Mechanism for Regulation of Tumor ProgressionComorbid Cannabis and Tobacco Use in Adolescents and AdultsNovel adamantyl cannabinoids as CB1 receptor probes.The analgesic potential of cannabinoids.Basic neuroanatomy and neuropharmacology of cannabinoids.Involvement of the endocannabinoid system in the physiological response to transient common carotid artery occlusion and reperfusion.Cannabis-related working memory deficits and associated subcortical morphological differences in healthy individuals and schizophrenia subjects.Lead discovery, chemistry optimization, and biological evaluation studies of novel biamide derivatives as CB2 receptor inverse agonists and osteoclast inhibitorsThe Impact of CB2 Receptor Ligands on the MK-801-Induced Hyperactivity in Mice.The endocannabinoid system in critical neurodevelopmental periods: sex differences and neuropsychiatric implications.Cannabinoids and the endocannabinoid system in lower urinary tract function and dysfunction.β-arrestins: regulatory role and therapeutic potential in opioid and cannabinoid receptor-mediated analgesia.Functions of the CB1 and CB 2 receptors in neuroprotection at the level of the blood-brain barrier.Septo-hippocampo-septal loop and memory formationInvestigational drugs under development for the treatment of PTSD.Cannabinoids as Modulators of Cell Death: Clinical Applications and Future Directions.Medical Cannabis in Serbia: The Survey of Knowledge and Attitudes in an Urban Adult Population.Recent Advances in the Realm of Allosteric Modulators for Opioid Receptors for Future Therapeutics.Potential Future Pharmacological Treatment of Bladder Dysfunction.
P2860
Q27673277-F41CCF04-9F5F-492A-B5FD-742BF131B650Q28292025-39795F2F-C305-4697-9115-7A67342059C3Q28566274-ED28AE32-71E7-4559-8D22-63F9FF8B6FCAQ30397741-CB3CF9F7-0754-454D-92F0-FA0FBAAA16CEQ33897801-91FF6A35-653F-4BC5-8A18-49735AAF09C8Q33999727-6FB74D32-B9CA-4F82-9523-D4699E881E30Q34194009-6301EB2C-C471-4EA5-8487-A446931F5D15Q34278947-C07580DC-C29C-4EBF-80CE-87B756F0BB52Q34369293-8AA95EF1-51C3-4577-AB0B-564050CD674FQ34415497-CBD2DD2E-F9AC-41A6-9FAE-D7C75CC07D0EQ34524896-6C50EAF9-AC82-4390-A7BB-4B95977059EFQ34998169-1B03F779-3163-41A2-A053-DB24F92AB37FQ35103574-7A94C091-551B-4149-ADA6-18BD0E265532Q35147183-38C56F34-9118-4438-B183-EF77E9F5E9B6Q35529832-2C65EEFA-DCD2-41CB-A720-775DD790F95BQ35893996-62A3B8CB-3E1D-4FFC-92C3-247F905D118BQ35984216-5988C079-FB07-4E63-8391-19433D42026EQ36003195-0D28B3B6-6BCA-4B03-AA3A-69E064654ED5Q36006338-D1AC37C9-E0D4-45E5-ABFF-9FB9B52E269FQ36287890-935648EC-6834-4E92-9C4D-B1E9E8893BE8Q36408464-670E1ED7-16D2-4C5C-A2A1-C5DD1C9F4787Q36876322-4C1C7FAA-6BF3-4114-8C89-118FA91630A2Q36884258-D092A3C2-E7D9-4427-BD91-42C6C0C43808Q36996148-013B1E8A-3D5A-460B-8436-1B56D4481A3BQ37057325-68F2FF63-7211-49A7-B5B0-8BE39893859AQ37444802-D666E11B-76D5-450C-8C4B-45A9E2C9AF0FQ37595794-43A0C9C7-07EA-4C90-BD72-5D522BE90F38Q37598266-3AF7B762-00F0-4B5A-9A56-43CE09544807Q37668664-6B1D0EBF-1056-44E7-BA5D-936345179057Q37714575-3182F89F-78E1-44EF-B580-865ABD7E25A4Q37888955-CBEF2414-D989-4840-BA27-B1C79B2F3969Q38166997-645FDD83-9A27-487C-B647-81A6E4A44E88Q38167644-63018650-BF32-4874-846E-4CECB0F1E4CFQ38220272-E91D6BFE-AAE4-45BD-837C-8EE0204416C6Q38261934-2A22E1AF-F362-4E94-8A10-37803B79876BQ38378939-D2A4AF69-EF2B-4897-8272-19EA7DBEA021Q38692926-CD52F577-0BB3-41AA-90C8-49D67A7FAA3FQ38717577-132CA9AD-B605-4ECB-BAFB-02F35B4D3B49Q38736252-3F12A3D0-6742-471E-B3E1-D3ED00810838Q38779624-A6E6AEE7-F2F9-4188-988A-4FEEF9ED7459
P2860
Cannabinoid receptors 1 and 2 (CB1 and CB2), their distribution, ligands and functional involvement in nervous system structures--a short review.
description
2008 nî lūn-bûn
@nan
2008 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
name
Cannabinoid receptors 1 and 2 ...... em structures--a short review.
@ast
Cannabinoid receptors 1 and 2 ...... em structures--a short review.
@en
Cannabinoid receptors 1 and 2 ...... em structures--a short review.
@nl
type
label
Cannabinoid receptors 1 and 2 ...... em structures--a short review.
@ast
Cannabinoid receptors 1 and 2 ...... em structures--a short review.
@en
Cannabinoid receptors 1 and 2 ...... em structures--a short review.
@nl
prefLabel
Cannabinoid receptors 1 and 2 ...... em structures--a short review.
@ast
Cannabinoid receptors 1 and 2 ...... em structures--a short review.
@en
Cannabinoid receptors 1 and 2 ...... em structures--a short review.
@nl
P2093
P921
P1476
Cannabinoid receptors 1 and 2 ...... em structures--a short review.
@en
P2093
Alexandra Sulcová
Ivana Svízenská
Petr Dubový
P304
P356
10.1016/J.PBB.2008.05.010
P407
P577
2008-10-01T00:00:00Z